Nonproprietary names

International nonproprietary name (INN), British approved name (BAN), Japanese accepted name (JAN), and United States adopted name (USAN). Only selected salts are included. Trade names shown can represent the base or any of the salts included in "Nomenclature". 

Avemiectin is the most effective of the averniectia family of natural products against agriculturally important insects and mites (14). It has been commercialized for agricultural use under the nonproprietary name abamectin. This mixture of avermectins contains at least 80% of avermectin (C4gH 20 and not more than 20% of avermectin B Abamectin for use in foHar spray appHcations is formulated as an emulsiftable... 

Selective reduction of the 22,23-olefin of avermectin yields the 22,23-dihydro derivative assigned the nonproprietary name ivermectin (18). The stmcture shown depicts the 25-j -butyl derivative [70161 -11-4] but it should be noted that both commercial products contain up to 20% of the 25-isopropyl... 

In the dmg field, there is a need for simple and useful nonproprietary names for dmgs. The United States Adopted Names (USAN) Council chooses generic names for dmgs used in the United States. A list is available (11). 

The nonproprietary name index published by Paul de Haen. ... 

Paul de Haen International, Inc., Nonproprietary Name Index, Englewood, CO, Paul de... 

Throughout the process of development, drags may have several names assigned to them a chemical name, a generic (nonproprietary) name, an official name, and a trade or brand name This is confusing unless the nurse has a clear understanding of the different names used. Table 1-1 identifies the different names and provides an explanation of each. 

Here, mab stands for monoclonal antibody. These letters appear before -mab. Programme on International Nonproprietary Names (INN) Division of Drug Management and Policies, World Health Organization, Geneva. 1997. Web address whalibdoc.who.int/hg/1 997/ WHO Pharm S NOM 1 570.pdf... 

Excipients should be listed in the composition using their Ph Eur name (or one from another national pharmacopeia from an EEA member state), the International Nonproprietary Name, or an exact scientific designation, other than for materials such as preservatives or coloring agents which can be identified by an E-number. Third country pharmacopeial names may be acceptable. Coloring matter is subject to the provisions of specific legislation in the EEA. 

Nonproprietary names Valproic acid, Sodium valproate... 

The Inscription is the general content of the prescription. It states the name and strength of the medication, either as its brand (proprietary) or generic (nonproprietary) name. In the case of compounded prescriptions, the inscription states the name and strength of active ingredients. 

It should be noted that there are normally three names associated with a drug the trade or proprietary name (e.g., Nexium), generic or nonproprietary name (esomeprazole), and a specific chemical name for the active ingredient. In the case of esomeprazole, the active ingredient is the S-isomer of benzimidazole. 

The drug diazepam may serve as an illustrative example. Chemically, this compound is called 7-chloro-l,3-dihy-dro-1 -methyl-5-phenyl-2H-l, 4-benzo-diazepin-2-one, a term too unwieldy for everyday use. A simpler name is diazepam. This is not a legally protected name but a generic (nonproprietary) name. An INN (= international nonproprietary name) is a generic name that has been agreed upon by an international commission. 

For the sake of clarity, only INNs or generic (nonproprietary) names are used in this atlas to designate drugs, such as the name diazepam" in the above example. 

Many a brand name is not listed in the index Proprietary Name Generic Name. In these cases, it will be useful to consult the packaging information, which should list the generic (nonproprietary) name or INN. 

Nations Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or not Approved by Governments. WHO publishes updates to this list Pharmaceuticals Restrictions in use and availability. WHO publishes also quarterly WHO Drug Information (http //www.who.int/druginformation/) journal which provides an overview of topics of current relevance relating to drug development, safety and regulation. Latest lists of proposed and recommended International Nonproprietary Names (INN) for Pharmaceutical Substances are also published in this journal. 

---